Press "Enter" to skip to content

New patent expiration for Takeda Pharms drug INTUNIV

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Takeda Pharms drug INTUNIV

Annual Drug Patent Expirations for INTUNIV
Annual Drug Patent Expirations for INTUNIV

Intuniv is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for INTUNIV.

The generic ingredient in INTUNIV is guanfacine hydrochloride. One supplier is listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Takeda Pharms drug INTUNIV
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions